サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1314490

尿検査市場：製品（消耗品、機器）、検査タイプ（生化学尿検査、沈渣尿検査）、用途、最終用途別-2023-2030年の世界予測

Urinalysis Market by Product (Consumables, Instruments), Test Type (Biochemical Urinalysis, Sediment Urinalysis), Application, End-Use - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
尿検査市場：製品（消耗品、機器）、検査タイプ（生化学尿検査、沈渣尿検査）、用途、最終用途別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

尿検査の世界市場は、2023年に42億628万米ドル、CAGR8.30％で大きく成長し、2030年には74億2,071万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の尿検査市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.尿検査の世界市場規模および予測は？

2.予測期間中、世界の尿検査市場を形成するCOVID-19の阻害要因と影響は？

3.尿検査の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.尿検査の世界市場における競争戦略は？

5.尿検査の世界市場における技術動向と規制の枠組みは？

6.尿検査の世界市場における主要ベンダーの市場シェアは？

7.尿検査の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で腎臓病と尿路感染症の有病率が増加
      • 早期の検査と管理のための政府の有利な取り組み

慢性疾患

      • 臨床検査室や病院でのポイントオブケア尿検査システムの採用の増加
    • 抑制要因
      • 製品リコールに対する重大な懸念
    • 機会
      • 腎バイオマーカーとsmaRT-LAMPシステムの技術進歩
      • 尿路感染症スクリーニング用自動分析装置の登場
    • 課題
      • 定期健康診断に対する意識の欠如と熟練した検査員の不足
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 尿検査市場：製品別

  • 消耗品
  • 楽器

第7章 尿検査市場テストタイプ別

  • 生化学の尿検査
  • 堆積物尿検査

第8章 尿検査市場：用途別

  • 糖尿病
  • 高血圧
  • 腎臓病
  • 肝臓病
  • 尿路感染症

第9章 尿検査市場：最終用途別

  • 臨床検査室
  • 在宅ヘルスケア
  • 病院
  • 調査と学術

第10章 南北アメリカの尿検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の尿検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの尿検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別
    • 合併・買収
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化
    • 受賞・表彰・拡大

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. URINALYSIS MARKET RESEARCH PROCESS
  • FIGURE 2. URINALYSIS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. URINALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. URINALYSIS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. URINALYSIS MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
  • FIGURE 6. URINALYSIS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. URINALYSIS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
  • FIGURE 8. URINALYSIS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. URINALYSIS MARKET DYNAMICS
  • FIGURE 10. URINALYSIS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. URINALYSIS MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. URINALYSIS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. URINALYSIS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS URINALYSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES URINALYSIS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. URINALYSIS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. URINALYSIS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. URINALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. URINALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. URINALYSIS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. URINALYSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. URINALYSIS MARKET SIZE, BY BIOCHEMICAL URINALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. URINALYSIS MARKET SIZE, BY SEDIMENT URINALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. URINALYSIS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. URINALYSIS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. URINALYSIS MARKET SIZE, BY KIDNEY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. URINALYSIS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. URINALYSIS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. URINALYSIS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. URINALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. URINALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. URINALYSIS MARKET SIZE, BY RESEARCH & ACADEMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES URINALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. URINALYSIS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 190. URINALYSIS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 191. URINALYSIS MARKET LICENSE & PRICING
目次
Product Code: MRR-034B5003034E

The Global Urinalysis Market is forecasted to grow significantly, with a projected USD 4,206.28 million in 2023 at a CAGR of 8.30% and expected to reach a staggering USD 7,420.71 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Urinalysis Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Urinalysis Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumables and Instruments. The Consumables commanded largest market share of 59.78% in 2022, followed by Instruments.

Based on Test Type, market is studied across Biochemical Urinalysis and Sediment Urinalysis. The Biochemical Urinalysis commanded largest market share of 58.55% in 2022, followed by Sediment Urinalysis.

Based on Application, market is studied across Diabetes, Hypertension, Kidney Diseases, Liver Diseases, and Urinary Tract Infections. The Kidney Diseases commanded largest market share of 33.21% in 2022, followed by Diabetes.

Based on End-Use, market is studied across Clinical Laboratories, Home Healthcare, Hospitals, and Research & Academics. The Clinical Laboratories commanded largest market share of 42.67% in 2022, followed by Hospitals.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific commanded largest market share of 36.72% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Urinalysis Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Urinalysis Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Urinalysis Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Urinalysis Market?

4. What is the competitive strategic window for opportunities in the Global Urinalysis Market?

5. What are the technology trends and regulatory frameworks in the Global Urinalysis Market?

6. What is the market share of the leading vendors in the Global Urinalysis Market?

7. What modes and strategic moves are considered suitable for entering the Global Urinalysis Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Urinalysis Market, by Product, 2022 vs 2030
  • 4.3. Urinalysis Market, by Test Type, 2022 vs 2030
  • 4.4. Urinalysis Market, by Application, 2022 vs 2030
  • 4.5. Urinalysis Market, by End-Use, 2022 vs 2030
  • 4.6. Urinalysis Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of kidney diseases and urinary tract infections worldwide
      • 5.1.1.2. Favorable government initiatives for early screening and management of

chronic diseases

      • 5.1.1.3. Rising adoption of point-of-care urinalysis systems in clinical laboratories and hospitals
    • 5.1.2. Restraints
      • 5.1.2.1. Significant concern for product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in renal biomarker and smaRT-LAMP system
      • 5.1.3.2. Emergence of automated analyzers for urinary tract infection screening
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness about routine health checkup and limited skilled laboratory workforce
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Urinalysis Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments

7. Urinalysis Market, by Test Type

  • 7.1. Introduction
  • 7.2. Biochemical Urinalysis
  • 7.3. Sediment Urinalysis

8. Urinalysis Market, by Application

  • 8.1. Introduction
  • 8.2. Diabetes
  • 8.3. Hypertension
  • 8.4. Kidney Diseases
  • 8.5. Liver Diseases
  • 8.6. Urinary Tract Infections

9. Urinalysis Market, by End-Use

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Home Healthcare
  • 9.4. Hospitals
  • 9.5. Research & Academics

10. Americas Urinalysis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Urinalysis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Urinalysis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Merger & Acquisition
      • 13.3.1.1. Diagnostics Firm Bio-Rad in Talks to Merge with Qiagen
      • 13.3.1.2. FemTec Health Acquires Ava AG, Reproductive Monitoring Pioneer
    • 13.3.2. Agreement, Collaboration, & Partnership
      • 13.3.2.1. Siemens Healthineers and Unilabs Launch Strategic Partnership for Latest Diagnostic Testing Infrastructure to Improve Patients' Care
    • 13.3.3. New Product Launch & Enhancement
      • 13.3.3.1. 2San Launches Several Home Testing Kits at MEDICA
      • 13.3.3.2. Olive Diagnostics Launches AI-Powered Urinalysis Device
    • 13.3.4. Award, Recognition, & Expansion
      • 13.3.4.1. Medtronic (MDT) Launches New Venture to Treat Kidney Failure
      • 13.3.4.2. Healthy.io Receives FDA Clearance for Smartphone-Based Home Kidney Test

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing